Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal epithelial cell transporter proteins are a diverse group of membrane-bound proteins primarily responsible for the regulated movement of ions, nutrients (such as sugars and amino acids), metabolites, and drugs across the intestinal epithelium. The most prominent among these are members of the solute carrier (SLC) superfamily and ATP-binding cassette (ABC) transporters. These proteins play essential roles in digestion by mediating absorption from the gut lumen into enterocytes and subsequently into circulation. They also contribute to electrolyte homeostasis and protect against xenobiotics by facilitating efflux back into the lumen. Dysfunction or altered expression can lead to diseases such as congenital diarrheal disorders, metabolic syndrome, inflammatory bowel diseases, and can impact oral drug bioavailability[1][2][7]. **Note:** "Intestinal epithelial cell transporter proteins" is not a single molecular entity but rather refers collectively to many different specific transporter molecules expressed in intestinal epithelial cells—such as SGLT1/SLC5A1 for glucose uptake; PEPT1/SLC15A1 for peptide uptake; NHE3/SLC9A3 for sodium/hydrogen exchange; CFTR/ABCC7 for chloride secretion; among others[4][7]. For structured data purposes it is preferable to specify individual transporter names when possible. **Reasoning about correctness:** This entry is too broad/vague ("intestinal epithelial cell transporter proteins" encompasses dozens if not hundreds of distinct targets). It should be mapped down to individual canonical forms such as "Sodium/glucose cotransporter 1", "Peptide transporter 1", etc.[2][4]
Inhibition or modulation of transporter activity to alter drug absorption or nutrient uptake
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal epithelial cell transporter protein.